Friday, May 20, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

PHEMCE Medical Countermeasure Stakeholders Workshop

by Global Biodefense Staff
November 19, 2015
PHEMC Medical Countermeasures Workshop

U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response will host a Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholder’s Workshop Jan. 6-7, 2016, in Bethesda, Maryland.

This two-day workshop will highlight past progress and future directions in developing, stockpiling and effectively utilizing the drugs, vaccines, and devices that may be required in public health emergencies caused by either naturally occurring epidemics or intentional chemical, biological, radiological and nuclear (CBRN) attacks.

The workshop will feature a mix of plenary sessions and in-depth breakout sessions along four tracks, addressing topics which include:

  • Clinical Guidance on the Use of Medical Countermeasures
  • Biosafety and Biosecurity
  • Post-Marketing Data On Safety and Efficacy for MCMs Approved Under Animal Rule
  • The Strategic National Stockpile
  • Science Needs During Crisis Response
  • Focusing On Populations with Special Needs
  • Influenza and Respiratory Pathogens Update
  • NIH Support and Services for Medical Countermeasure Development
  • Combating Antibiotic Resistant Bacteria Program
  • Past, Present and Future of the MCM Initiative at FDA
  • The MERS CoV Connection
  • Ebola Response – After Action Report

Advance registration is required for the PHEMCE Stakeholders Workshop. Registration will close on December 11, 2015 or when the event reaches capacity.

Source: PHE.gov, adapted.

Tags: AntimicrobialsAntitoxinsAntiviralsBiosafetyEbolaEmerging ThreatsInfluenzaMERS-CoVPandemicVaccines

Related Posts

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster
Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Congenital Syphilis Continues a Decade-Long Surge Across the US
Infectious Diseases

Congenital Syphilis Continues a Decade-Long Surge Across the US

April 12, 2022
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC